Risk of Gambling Disorder and Impulse Control Disorder with Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study

Journal of Clinical Psychopharmacology

Volumn 37, Issue 1, 2017, Pages 102-104

  Etminan, Mahyar ^a   Sodhi, Mohit ^a   Samii, Ali ^b   Procyshyn, Ric M ^c   Guo, Michael ^a   Carleton, Bruce C ^d,e,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Washington ^*  (Japan)

^d Faculty of Medicine   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f BC CHILDREN S HOSPITAL   (Canada)

Author keywords

aripiprazole; impulse control disorder; pathologic gambling; pharmacoepidemiology

Indexed keywords

ARIPIPRAZOLE; PRAMIPEXOLE; RANITIDINE; ROPINIROLE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; INDOLE DERIVATIVE; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; ADVERSE DRUG REACTION; CANADA; CHEMICALLY INDUCED; COHORT ANALYSIS; GAMBLING; MIDDLE AGED;

ADULT; ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; BENZOTHIAZOLES; CANADA; CASE-CONTROL STUDIES; COHORT STUDIES; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; DOPAMINE AGONISTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GAMBLING; HUMANS; INDOLES; MALE; MIDDLE AGED;

EID: 85001977474     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000634     Document Type: Article

References (10)

1. Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med. 2014;174:1930-1933.
2. FDA Drug Safety Communication. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm498662.htm. Accessed May 11, 2016.
3. Grall-Bronnec M, Sauvaget A, Perrouin F, et al. Pathological gambling associated with aripiprazole or dopamine replacement therapy: do patients share the same features A review. J Clin Psychopharmacol. 2016;36: 63-70.
4. Roxanas MG. Pathological gambling and compulsive eating associated with aripiprazole. Aust N Z J Psychiatry. 2010;44:291.
5. PDSP Ki Database, University of North Carolina. Available at: http://kidbdev.med.unc.edu/databases/kidb.php. Accessed September 12, 2016.
6. EtminanM, Carleton B, Brophy JM. Risperidone and risk of gynecomastia in young men. J Child Adolesc Psychopharmacol. 2015;25:671-673.
7. Nocjar C, Panksepp J. Chronic intermittent amphetamine pretreatment enhances future appetitive behavior for drug-and natural-reward: interaction with environmental variables. Behav Brain Res. 2002;128: 189-203.
8. O'Sullivan SS, Wu K, Politis M, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain. 2011;134:969-978.
9. Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol. 2005;62:1377-1381.
10. Ye Z, Hammer A, Camara E, et al. Pramipexole modulates the neural network of reward anticipation. Hum Brain Mapp. 2011;32:800-811.